Analystreport

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Soleno Therapeutics, Inc.  (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview